ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ANRO Alto Neuroscience Inc

12.47
-0.35 (-2.73%)
May 17 2024 - Closed
Delayed by 15 minutes

Alto Neuroscience Financial Summary

The current ANRO market cap is 334.12M. The company's latest EPS is USD -1.3550 and P/E is -9.19.

Quarter End
USD ($)USD ($)
Total Revenue
Operating Income
Net Income
Year End December 30 2023 20222023
USD ($)USD ($)
Total Revenue 00
Operating Income -29.19M-37.81M
Net Income -27.71M-36.31M
Quarter End
USD ($)USD ($)
Total Assets
Total Liabilities
Total Equity
Year End December 30 2023 20222023
USD ($)USD ($)
Total Assets 50.85M86.63M
Total Liabilities 17.03M16.82M
Total Equity -38.41M-71.67M
Quarter End
USD ($)USD ($)
Operating
Investing
Financing
Year End December 30 2023 20222023
USD ($)USD ($)
Operating -20.39M-33.45M
Investing -732k-470k
Financing 43.79M68.13M
Market Cap 334.12M
Price to Earnings Ratio -9.19
Price to Sales Ratio 0
Price to Cash Ratio 4.04
Price to Book Ratio 4.78
Dividend Yield -

Share Statistics

Shares Outstanding 26.79M
Average Volume (1 week) 87.87k
Average Volume (1 Month) 86.4k
52 Week Change -43.32%
52 Week High 24.00
52 Week Low 12.17
Spread (Intraday) 5.08 (31.75%)

Company Info

Company Name Alto Neuroscience Inc
Address corporation trust center
wilmington, delaware 19801
Website https://www.altoneuroscience.com
Industry pharmaceutical preparations (2834)